Video

Stacey Cofield, PhD

Publish date: May 7, 2015

Dr. Stacey Cofield discusses marijuana use and disability self-reported by MS patients in the NARCOMS patient registry.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Switch to Oral Fingolimod May Improve MS Outcomes
MDedge Neurology
Conference News Update—Federation of American Societies for Experimental Biology
MDedge Neurology
Can FLAIR MRI Show Treatment Efficacy?
MDedge Neurology
Using the GAD-7 Scale in Multiple Sclerosis Patients
MDedge Neurology
Concurrent Autoimmune Diseases in MS
MDedge Neurology
Does Pharmacy-Directed Treatment Management Improve Care?
MDedge Neurology
MSC Consensus Paper on DMTs in MS
MDedge Neurology
Robert Fox, MD
MDedge Neurology
Peginterferon beta-1a MS data show positive early and long-term results
MDedge Neurology
AAN: Study supports safety of fingolimod for MS
MDedge Neurology